Celestica Announces Board Leadership Transition and Appoints New Director
CLS has more than doubled off its 52-week low of $58.05.
Summary
Celestica announced a leadership transition on its Board of Directors, with the current CEO assuming the Chair role, a new Lead Independent Director appointed, and a highly experienced executive joining the board.
Key Events · Executive and Board Changes · CLS
-
Chair Retirement
Michael M. Wilson will retire as Chair of the Board of Directors, effective immediately prior to the 2026 Annual Meeting of Shareholders, consistent with the company's director retirement policy.
-
CEO Assumes Chair Role
Robert A. Mionis, the current President and CEO, has been appointed as Chair of the Board, effective immediately prior to the 2026 Annual Meeting.
-
Lead Independent Director Appointed
Laurette T. Koellner has been appointed as Lead Independent Director of the Board, effective immediately prior to the 2026 Annual Meeting, to provide independent oversight.
-
New Independent Director Appointed
David Reeder, an experienced executive with expertise in global semiconductor and technology enterprises, has been appointed as an independent director to the Board, effective May 1, 2026. He will serve on the Audit, Human Resources and Compensation, and Nominating and Corporate Governance Committees.
Analysis · CLS · Manufacturing
Celestica is undergoing a planned leadership transition on its Board of Directors. Michael Wilson is retiring as Chair, consistent with company policy. Robert Mionis, the current President and CEO, will assume the role of Chair, combining the CEO and Chair positions. To maintain strong governance, Laurette Koellner has been appointed as Lead Independent Director. Additionally, David Reeder, an executive with extensive experience in the semiconductor and technology sectors, including CFO roles at major companies, has been appointed as an independent director. This move strengthens the board's expertise in key areas relevant to Celestica's business strategy.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 30.2% of the 1605 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.53%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CLS was trading at $300.07 on NYSE in the Manufacturing sector, with a market capitalization of approximately $34.7B. The 52-week trading range was $58.05 to $363.40. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.